These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Targeted gene expression in the chicken eye by in ovo electroporation. Chen YX; Krull CE; Reneker LW Mol Vis; 2004 Nov; 10():874-83. PubMed ID: 15570216 [TBL] [Abstract][Full Text] [Related]
24. Lentivirus-mediated gene transfer of interleukin 10 to the ovine and human cornea. Parker DG; Coster DJ; Brereton HM; Hart PH; Koldej R; Anson DS; Williams KA Clin Exp Ophthalmol; 2010 May; 38(4):405-13. PubMed ID: 20491805 [TBL] [Abstract][Full Text] [Related]
25. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620 [TBL] [Abstract][Full Text] [Related]
30. In vivo liver electroporation: optimization and demonstration of therapeutic efficacy. Jaichandran S; Yap ST; Khoo AB; Ho LP; Tien SL; Kon OL Hum Gene Ther; 2006 Mar; 17(3):362-75. PubMed ID: 16544985 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of TTR and CMV promoters in vivo and in vitro via a secreted luciferase reporter system]. Luo ST; Tian WH; Wang G; Dong XY; Yang L; Wu XB Bing Du Xue Bao; 2009 Nov; 25(6):424-9. PubMed ID: 20077932 [TBL] [Abstract][Full Text] [Related]
32. A novel ex vivo angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA to skeletal muscle. Jang HS; Kim HJ; Kim JM; Lee YS; Kim KL; Kim JA; Lee JY; Suh W; Choi JH; Jeon ES; Byun J; Kim DK Mol Ther; 2004 Mar; 9(3):464-74. PubMed ID: 15006615 [TBL] [Abstract][Full Text] [Related]
33. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression. Liu BH; Wang X; Ma YX; Wang S Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697 [TBL] [Abstract][Full Text] [Related]
34. Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis. Adachi O; Nakano A; Sato O; Kawamoto S; Tahara H; Toyoda N; Yamato E; Matsumori A; Tabayashi K; Miyazaki J Gene Ther; 2002 May; 9(9):577-83. PubMed ID: 11973633 [TBL] [Abstract][Full Text] [Related]
35. Optimization of gene transfer into neonatal rat cardiomyocytes and unmasking of cytomegalovirus promoter silencing. Bauer S; Maier SK; Neyses L; Maass AH DNA Cell Biol; 2005 Jun; 24(6):381-7. PubMed ID: 15941390 [TBL] [Abstract][Full Text] [Related]
36. Prolonged amelioration of acute lung allograft rejection by overexpression of human interleukin-10 under control of a long acting ubiquitin C promoter in rats. Stammberger U; Bilici M; Gugger M; Gazdhar A; Hamacher J; Hyde SC; Schmid RA J Heart Lung Transplant; 2006 Dec; 25(12):1474-9. PubMed ID: 17178344 [TBL] [Abstract][Full Text] [Related]
37. Efficient gene transfer into zebrafish skeletal muscle by intramuscular injection of plasmid DNA. Tan JH; Chan WK Mol Mar Biol Biotechnol; 1997 Jun; 6(2):98-109. PubMed ID: 9200836 [TBL] [Abstract][Full Text] [Related]
38. Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells. Davis MG; Huang ES Biotechnol Appl Biochem; 1988 Feb; 10(1):6-12. PubMed ID: 2841949 [TBL] [Abstract][Full Text] [Related]
39. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Hartikka J; Sukhu L; Buchner C; Hazard D; Bozoukova V; Margalith M; Nishioka WK; Wheeler CJ; Manthorp M; Sawdey M Mol Ther; 2001 Nov; 4(5):407-15. PubMed ID: 11708877 [TBL] [Abstract][Full Text] [Related]
40. Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid. Li S; MacLaughlin FC; Fewell JG; Gondo M; Wang J; Nicol F; Dean DA; Smith LC Gene Ther; 2001 Mar; 8(6):494-7. PubMed ID: 11313829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]